ABVC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ABVC Biopharma Inc is not a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock exhibits weak financial performance, bearish technical indicators, and lacks positive catalysts or significant trading signals to suggest a favorable entry point. Given the investor's profile, this stock does not align with their investment goals.
The stock exhibits bearish technical indicators: the MACD histogram is negative and expanding downward (-0.00989), RSI is at 21.402 (neutral zone), and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). Key support levels are at 1.079 and 0.988, with resistance at 1.376 and 1.467. The price is currently below the pivot point of 1.228, indicating a downward trend.
NULL identified. There are no recent news events, no significant trading trends from hedge funds or insiders, and no recent congress trading data.
and IV rank (100), indicating elevated risk.
The company's Q4 2025 financials show severe declines across all key metrics: revenue, net income, EPS, and gross margin have all dropped significantly, reflecting poor financial health and no signs of growth.
No analyst ratings or price target changes are available for ABVC. This lack of coverage may indicate limited interest or confidence in the stock from the analyst community.
